Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-19

Clinical Trial Update: A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death [Phase 3]

View source ↗

Summary

A randomized Phase 3 trial comparing two regimens of misoprostol for second-trimester termination in intrauterine fetal death was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Labor Induction | Phase 3 | Status: TERMINATED